NORTHERN TRUST CORP - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$9,288,838
-9.8%
517,484
+2.0%
0.00%0.0%
Q2 2023$10,303,567
+6.4%
507,315
-4.5%
0.00%0.0%
Q1 2023$9,684,985
-34.1%
530,975
-25.3%
0.00%
-33.3%
Q4 2022$14,695,663
-18.9%
710,622
+2.5%
0.00%
-25.0%
Q3 2022$18,130,000
+5.0%
693,008
+1.7%
0.00%0.0%
Q2 2022$17,270,000
-8.9%
681,550
+13.5%
0.00%
+33.3%
Q1 2022$18,948,000
-25.0%
600,408
-3.8%
0.00%
-25.0%
Q4 2021$25,264,000
+13.2%
624,270
-2.5%
0.00%0.0%
Q3 2021$22,325,000
+21.7%
640,232
-4.2%
0.00%
+33.3%
Q2 2021$18,348,000
+30.5%
668,181
+33.4%
0.00%0.0%
Q1 2021$14,063,000
+1.2%
500,846
-6.5%
0.00%0.0%
Q4 2020$13,903,000
+46.8%
535,565
-3.1%
0.00%
+50.0%
Q3 2020$9,469,000
-21.4%
552,448
+13.4%
0.00%
-33.3%
Q2 2020$12,050,000
+116.1%
487,083
+21.2%
0.00%
+50.0%
Q1 2020$5,577,000
+42.7%
401,831
+3.9%
0.00%
+100.0%
Q4 2019$3,907,000
+18.0%
386,867
+6.3%
0.00%0.0%
Q3 2019$3,311,000
+25.3%
363,822
+9.5%
0.00%0.0%
Q2 2019$2,642,000
-32.5%
332,256
+6.0%
0.00%0.0%
Q1 2019$3,916,000
+19.9%
313,560
+3.4%
0.00%0.0%
Q4 2018$3,265,000
+125.5%
303,109
+191.6%
0.00%
Q3 2018$1,448,000
+87.1%
103,934
+64.5%
0.00%
Q2 2018$774,00063,1990.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders